As shown in Fig. 1c, treating cells with exogenous LIF (100 ng/ml) dramatically promoted the abilities of invasion and migration of all these 3 breast cancer cell lines, which can be blocked by LIF neutralization antibody. The gene discussed is LIF; the disease is breast carcinoma.